HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
W G Forssmann Selected Research
W G Forssmann Research Topics
Disease
3
Neoplasms (Cancer)
09/2001 - 11/2000
2
Inflammation (Inflammations)
10/2008 - 12/2005
1
Contracture
09/2012
1
Hemorrhage
08/2009
1
Postmenopausal Osteoporosis
01/2007
1
Osteosarcoma (Osteogenic Sarcoma)
01/2007
1
Skin Diseases (Skin Disease)
12/2005
1
Netherton Syndrome
12/2005
1
Atopic Dermatitis (Atopic Eczema)
12/2005
1
Communicable Diseases (Infectious Diseases)
12/2001
1
Pulmonary Hypertension
08/2001
1
Chronic Kidney Failure (Chronic Renal Failure)
05/2000
1
Osteoporosis
01/2000
1
Erectile Dysfunction
01/2000
Drug/Important Bio-Agent (IBA)
3
Peptides (Polypeptides)
IBA
09/2012 - 05/2000
2
Parathyroid Hormone (Parathormone)
IBA
01/2007 - 01/2000
1
Neurotoxins
IBA
09/2012
1
Cardiotoxins
IBA
09/2012
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
09/2012
1
CCR2 Receptors
IBA
10/2008
1
Chemokine Receptors
IBA
10/2008
1
Alkaline Phosphatase
IBA
01/2007
1
Peptide Hydrolases (Proteases)
FDA Link
12/2005
1
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
12/2005
1
Defensins
IBA
12/2001
1
beta-Defensins
IBA
12/2001
1
Biological Products
IBA
12/2001
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2001
1
Chemokines
IBA
09/2001
1
Fibrinolysin
FDA Link
09/2001
1
Phosphodiesterase 5 Inhibitors
IBA
08/2001
1
Dipyridamole (Persantine)
FDA Link
Generic
08/2001
1
Guanylate Cyclase (Guanylyl Cyclase)
IBA
08/2001
1
Thromboxanes
IBA
08/2001
1
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
IBA
08/2001
1
Natriuretic Peptides
IBA
08/2001
1
Ularitide
IBA
08/2001
1
Pharmaceutical Preparations
IBA
01/2001
1
Proteins (Proteins, Gene)
FDA Link
01/2001
1
Endostatins
IBA
01/2001
1
Collagen Type XVIII (Type XVIII Collagen)
IBA
01/2001
1
Chemotactic Factors
IBA
11/2000
1
Calcium
IBA
01/2000
1
Sildenafil Citrate (Viagra)
FDA Link
01/2000
1
Guanosine Monophosphate (5' Guanylic Acid)
IBA
01/2000
1
Type 5 Cyclic Nucleotide Phosphodiesterases
IBA
01/2000
Therapy/Procedure
4
Therapeutics
08/2009 - 01/2000